Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “2- HIV Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00985647
What this trial is testing

Pharmacokinetics of Lamivudine at Two Different Doses

Who this might be right for
HIV Infections
Kirby Institute 24
Not applicableStudy completedNCT00223314
What this trial is testing

Safer Choices 2 - HIV, STD, & Pregnancy Prevention Program

Who this might be right for
HIVSexually Transmitted DiseasesPregnancy+1 more
The University of Texas Health Science Center, Houston 1,000
Large-scale testing (Phase 3)Study completedNCT00197678
What this trial is testing

Multivitamin Dosage Regimens in the Prevention of Adverse Pregnancy Outcomes Among HIV-Positive Women

Who this might be right for
HIV Infections
Harvard School of Public Health (HSPH) 1,141
Testing effectiveness (Phase 2)Study completedNCT01269515
What this trial is testing

Immunomodulating Therapy and Improved Vaccination Responses by Cox-2 Inhibitor in HIV-infected Patients

Who this might be right for
HIV
Dag Kvale 60
Not applicableStudy completedNCT01159743
What this trial is testing

A Comparison of Body Fat Distribution in HIV-1 Infected Patients Receiving, Since the Beginning and for at Least Two Years, an Antiretroviral Therapy Based on Efavirenz or Lopinavir/Ritonavir Combined With Tenofovir + Emtricitabine or Lamivudine

Who this might be right for
HIV Infection
AbbVie (prior sponsor, Abbott) 346
Not applicableStudy completedNCT01721798
What this trial is testing

Comparison of Two Intrauterine Devices (IUDs) Among Cape Town HIV-positive Women

Who this might be right for
HIV
FHI 360 199
Testing effectiveness (Phase 2)Study completedNCT02384967
What this trial is testing

Evaluation of a Dose Reduction of Darunavir (400 mg/d) in Virologically Suppressed HIV-1 Patients

Who this might be right for
HIV INFECTION
ANRS, Emerging Infectious Diseases 100
Early research (Phase 1)UnknownNCT05863585
What this trial is testing

A Clinical Trial to Evaluate the Safety and Immunogenicity of a Prophylactic HIV Vaccine Candidate

Who this might be right for
Hiv
International AIDS Vaccine Initiative 14
Post-approval studies (Phase 4)Study completedNCT02198443
What this trial is testing

Comparison of Two Combinations in Antiretroviral Post-Exposure Prophylaxis for HIV-1: Tenofovir/Emtricitabine (Truvada ®) + Lopinavir/Ritonavir (Kaletra ®) vs Tenofovir/Emtricitabine/Cobicistat/Elvitegravir (Stribild ®). Prospective, Randomized, Open.

Who this might be right for
HIV
Fundacion Clinic per a la Recerca Biomédica 160
Testing effectiveness (Phase 2)WithdrawnNCT05130086
What this trial is testing

Islatravir (MK-8591) in Trans and Gender Diverse Participants (MK-8591-035)

Who this might be right for
Human Immunodeficiency Virus (HIV) Infections
Merck Sharp & Dohme LLC
Testing effectiveness (Phase 2)Study completedNCT00122486
What this trial is testing

Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV

Who this might be right for
HIV Infections
FHI 360 1,200
Early research (Phase 1)Study completedNCT01876966
What this trial is testing

Interaction Between Etravirine or Darunavir/Ritonavir and Artemether / Lumefantrine

Who this might be right for
HIV
Janssen Pharmaceutica N.V., Belgium 33
Post-approval studies (Phase 4)Ended earlyNCT02743598
What this trial is testing

Liraglutide for HIV-associated Neurocognitive Disorder

Who this might be right for
HIV InfectionDiabetes Mellitus Type 2Obesity+2 more
Temple University 4
Early research (Phase 1)Looking for participantsNCT06626230
What this trial is testing

Safety of Anal Curcumin

Who this might be right for
Anal High Grade Squamous Intraepithelial Lesion
Lisa Flowers 48
Early research (Phase 1)Study completedNCT02508064
What this trial is testing

Bioavailability of BMS-626529 in Healthy Subjects From Prototype Low Dose Extended Release Formulations (Part 1) and Prototype Extended Release Multi-particulate Formulations (Part 2) of BMS-663068 Relative to 600 mg Extended Release Tablet

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 27
Testing effectiveness (Phase 2)Study completedNCT00000979
What this trial is testing

Comparison of ddI Versus Zidovudine in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,500
Not applicableStudy completedNCT01997346
What this trial is testing

Multi-level Determinants of Starting ART Late: Aim 2

Who this might be right for
Human Immunodeficiency Virus (HIV)Acquired Immune Deficiency Syndrome (AIDS)
Columbia University 136
Not applicableUnknownNCT00011089
What this trial is testing

Tenofovir Disoproxil Fumarate in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drug Combinations

Who this might be right for
HIV Infections
Gilead Sciences
Post-approval studies (Phase 4)Study completedNCT00002386
What this trial is testing

Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With Hemophilia

Who this might be right for
HIV InfectionsHemophilia A
Merck Sharp & Dohme LLC 55
Testing effectiveness (Phase 2)Study completedNCT02457689
What this trial is testing

The Safety and Immunogenicity of the DNA-GTU Vaccine Administered to HIV-infected Patients on ART vs Placebo

Who this might be right for
HIV
Imperial College London 30
Next Page